ReviewShock (Augusta, Ga.)2025
Implications of Protein Posttranslational Modifications in Sepsis-Induced Acute Lung Injury and Acute Respiratory Distress Syndrome.
Review in Shock (Augusta, Ga.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis, a complex clinical syndrome, is characterized by the body's excessive response to infection, which triggers systemic inflammation. The lungs are the most vulnerable organs in patients with this disease, leading to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) as common complications of sepsis. These complications significantly increase the risk of death for patients, profoundly affect their prognosis, and impose significant burdens on public health. Posttranslational modifications (PTMs) of proteins play a critical role in regulating protein solubility, activity, stability, and mediating protein-protein interactions. Any changes in homeostasis in the body can affect cellular function by altering PTMs, thereby promoting the development of ALI/ARDS. This review focuses on several validated PTMs and explores their specific mechanisms of action in sepsis-induced ALI/ARDS. We hope to provide novel insights for understanding the occurrence and development of the disease by summarizing existing research results and to provide a theoretical basis for the formulation of diagnosis and treatment strategies. Furthermore, future research directions will be discussed with the goal of advancing targeted therapies against PTMs to enhance clinical outcomes for patients suffering from sepsis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.